Clinical Trial Update: Bone Loss and Immune Reconstitution in HIV/AIDS (BLIR-HIV) [Phase 2]

View source ↗

Summary

BLIR-HIV is a Phase 2 trial evaluating bone loss and immune reconstitution in people with HIV/AIDS; results were posted after the study completed in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Osteopenia
• Osteoporosis

Snippet

Sponsor: Emory University | Conditions: HIV Infection, Bone Loss | Phase 2 | Status: COMPLETED | Results posted: 2018-06-26